193 related articles for article (PubMed ID: 34587945)
1. Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study.
Dong L; Wei W; Han M; Xu G
Lipids Health Dis; 2021 Sep; 20(1):122. PubMed ID: 34587945
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.
Dong L; Li YQ; Guo SM; Xu G; Wei W; Han M
Front Immunol; 2022; 13():905930. PubMed ID: 35784308
[TBL] [Abstract][Full Text] [Related]
3. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neutrophil-to-lymphocyte ratio on proteinuria remission in patients with idiopathic membranous nephropathy.
Gan W; Chen J; Zhu F; Fang X; Zeng X; Xiao W; Chen W
Int Urol Nephrol; 2024 Mar; 56(3):1185-1193. PubMed ID: 37733125
[TBL] [Abstract][Full Text] [Related]
5. sPLA2-IB Level Correlates with Hyperlipidemia and the Prognosis of Idiopathic Membranous Nephropathy.
Yang LY; Wu YS; Dai BB; Lin SH; Chen H; Li GP; Tao X; Wan JX; Pan YB
Curr Med Sci; 2020 Aug; 40(4):683-690. PubMed ID: 32862379
[TBL] [Abstract][Full Text] [Related]
6. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
9. The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study.
Xie Z; Li Z; Dong W; Chen Y; Li R; Wu Y; Liang H; Ye Z; Liu S; Shi W; Liang X
BMC Nephrol; 2020 Jun; 21(1):224. PubMed ID: 32532223
[TBL] [Abstract][Full Text] [Related]
10. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
11. The ratio of neutrophils to lymphocytes effectively predicts clinical outcomes in idiopathic membranous nephropathy.
Zhao Q; Liu XQ; Jiang TT; Wang MY; Liu WT; Huang Y; Huang YL; Jin FY; Wu QY; Wang GH; Ruan XZ; Ma KL
Clin Nephrol; 2024 Mar; 101(3):101-108. PubMed ID: 38126194
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
[TBL] [Abstract][Full Text] [Related]
13. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
14. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
15. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy.
Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C
Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction.
Wang P; Wang S; Huang B; Liu Y; Liu Y; Chen H; Zhang J
Front Endocrinol (Lausanne); 2023; 14():1133521. PubMed ID: 37008916
[TBL] [Abstract][Full Text] [Related]
17. New risk score for predicting progression of membranous nephropathy.
Xiaofan H; Jing X; Chenni G; Yifan W; Xialian Y; Li L; Hong R; Wen Z; Weiming W; Xiaoxia P; Jingyuan X; Nan C
J Transl Med; 2019 Feb; 17(1):41. PubMed ID: 30736804
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Chen X; Chen Y; Shi K; Lv Y; Tong H; Zhao G; Chen C; Chen B; Li D; Lu Z
Sci Rep; 2017 Sep; 7(1):11468. PubMed ID: 28904360
[TBL] [Abstract][Full Text] [Related]
20. Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time.
Zhang N; Dai H; Dong X; Liu W; Jiang H; Zhao Q; Gao Y; Feng Z; Dong Z; Hu Y; Huang G; Rui H; Liu B
Front Immunol; 2022; 13():926368. PubMed ID: 35983038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
